Back
Intapp, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
28
INTA
Intapp, Inc.
Last Price:
$43.23
Seasonality Move:
11.57%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$87.93
Seasonality Move:
10.35%
Sell
28
Intapp, Inc. (INTA)
is a Sell
Is Intapp, Inc. a Buy, Sell or Hold?
-
The current Intapp, Inc. [INTA] share price is $43.24. The Score for INTA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
INTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
INTA Stock Price Chart
What is Intapp, Inc.'s stock price today?
-
The Intapp, Inc. share price today is $43.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INTA is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $87.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
INTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.81 | Buy |
| Relative Strength Index (14 RSI): | 56.14 | Buy |
| Chaikin Money Flow: | 107183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.43 - 43.65) | Buy |
| Bollinger Bands (100): | (38.81 - 44.09) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.53 | Buy |
| Relative Strength Index (14 RSI): | 71.11 | Buy |
| Chaikin Money Flow: | -592960 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.18 - 78.14) | Buy |
| Bollinger Bands (100): | (43.11 - 66.09) | Buy |
INTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.5 | Sell |
| 20-day SMA: | 42.47 | Buy |
| 50-day SMA: | 40.34 | Buy |
| 200-day SMA: | 48.09 | Sell |
| 8-day EMA: | 43.12 | Buy |
| 20-day EMA: | 42.41 | Buy |
| 50-day EMA: | 41.72 | Buy |
| 200-day EMA: | 45.99 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.75 | Buy |
| 20-day SMA: | 70.43 | Buy |
| 50-day SMA: | 63.87 | Buy |
| 200-day SMA: | 45.05 | Buy |
| 8-day EMA: | 80.77 | Buy |
| 20-day EMA: | 72.92 | Buy |
| 50-day EMA: | 64.9 | Buy |
| 200-day EMA: | 50.57 | Buy |
Intapp, Inc. Earnings Growth & INTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.27 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.
Intapp, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||